REVVITY, INC (RVTY) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-07-05..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-07-05..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-07-05..
Borrowing debt
Overview →Financial period ending 2026-07-05; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-07-05. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-07-05. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-07-05. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 572.16M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 2.63B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 12.05B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-07-05 | (m) | (m) | $572.16M | $2.63B | (m) | (m) | $12.05B | (m) |
| 2026-04-05 | (m) | (m) | $575.83M | $2.63B | (m) | (m) | $12.00B | (m) |
| 2025-12-28 | (m) | (m) | $588.83M | $2.63B | (m) | (m) | $12.17B | (m) |
| 2025-09-28 | (m) | (m) | $583.84M | $2.63B | (m) | (m) | $12.14B | (m) |
| 2025-06-29 | (m) | (m) | $230.00K | $3.21B | (m) | (m) | $12.36B | (m) |
| 2025-03-30 | (m) | (m) | $242.00K | $3.17B | (m) | (m) | $12.36B | (m) |
| 2024-12-29 | (m) | (m) | $242.00K | $3.15B | (m) | $1.16B | $12.39B | (m) |
| 2024-09-29 | (m) | (m) | $1.04M | $3.19B | (m) | $1.23B | $12.77B | (m) |
| 2024-06-30 | (m) | (m) | $711.41M | $3.16B | (m) | $1.95B | $13.42B | (m) |
| 2024-03-31 | (m) | (m) | $711.44M | $3.16B | (m) | $1.70B | $13.43B | (m) |
| 2023-12-31 | (m) | (m) | $721.87M | $3.18B | (m) | $1.60B | $13.56B | (m) |
| 2023-10-01 | (m) | (m) | $727.54M | $3.15B | (m) | $1.43B | $13.42B | (m) |
| 2023-07-02 | (m) | (m) | $478.94M | $3.88B | (m) | $2.07B | $14.22B | (m) |
| 2023-04-02 | (m) | (m) | $479.42M | $3.88B | (m) | $2.46B | $14.64B | (m) |
| 2023-01-01 | (m) | (m) | $470.93M | $3.92B | (m) | (m) | $14.13B | (m) |
| 2022-10-02 | (m) | (m) | $503.55M | $3.90B | (m) | (m) | $13.82B | (m) |
| 2022-07-03 | (m) | (m) | $4.18M | $4.48B | (m) | (m) | $14.19B | (m) |
| 2022-04-03 | (m) | (m) | $3.73M | $4.86B | (m) | (m) | $14.85B | (m) |
| 2022-01-02 | (m) | (m) | (m) | $4.98B | (m) | (m) | $15.00B | (m) |
| 2021-10-03 | (m) | (m) | $4.49M | $5.10B | (m) | (m) | $14.90B | (m) |
| 2021-07-04 | (m) | (m) | $4.67M | $2.35B | (m) | (m) | $8.74B | (m) |
| 2021-04-04 | (m) | (m) | $358.44M | $2.22B | (m) | (m) | $8.76B | (m) |
| 2021-01-03 | (m) | (m) | (m) | $1.61B | (m) | (m) | $7.96B | (m) |
| 2020-10-04 | (m) | (m) | $360.22M | $1.49B | (m) | (m) | $6.87B | (m) |
| 2020-07-05 | (m) | (m) | $346.34M | $1.62B | (m) | (m) | $6.64B | (m) |
| 2020-04-05 | (m) | (m) | $9.65M | $2.01B | (m) | (m) | $6.38B | (m) |
| 2019-12-29 | (m) | (m) | (m) | $2.06B | (m) | (m) | $6.54B | (m) |
| 2019-09-29 | (m) | (m) | $506.65M | $1.75B | (m) | (m) | $6.49B | (m) |
| 2019-06-30 | (m) | (m) | $8.21M | $2.10B | (m) | (m) | $6.40B | (m) |
| 2019-03-31 | (m) | (m) | $13.33M | $1.85B | (m) | (m) | $6.09B | (m) |
| 2018-12-30 | (m) | (m) | (m) | $1.88B | (m) | (m) | $5.98B | (m) |
| 2018-09-30 | (m) | (m) | $20.07M | $1.88B | (m) | (m) | $5.86B | (m) |
| 2018-07-01 | (m) | (m) | $17.32M | $1.98B | (m) | (m) | $5.96B | (m) |
| 2018-04-01 | (m) | (m) | $217.75M | $1.86B | (m) | (m) | $6.13B | (m) |
| 2017-12-31 | (m) | (m) | (m) | $1.79B | (m) | (m) | $6.09B | (m) |
| 2017-10-01 | (m) | (m) | $1.29M | $1.11B | (m) | (m) | $4.74B | (m) |
| 2017-07-02 | (m) | (m) | $2.23M | $1.09B | (m) | (m) | $4.61B | (m) |
| 2017-04-02 | (m) | (m) | $2.19M | $1.05B | (m) | (m) | $4.34B | (m) |
| 2017-01-01 | (m) | (m) | (m) | $1.05B | (m) | (m) | $4.28B | (m) |
| 2016-10-02 | (m) | (m) | $1.16M | $1.13B | (m) | (m) | $4.30B | (m) |
| 2016-07-03 | (m) | (m) | $1.15M | $1.06B | (m) | (m) | $4.19B | (m) |
| 2016-04-03 | (m) | (m) | $1.14M | $1.12B | (m) | (m) | $4.21B | (m) |
| 2016-01-03 | (m) | (m) | (m) | $1.01B | (m) | (m) | $4.17B | (m) |
| 2015-10-04 | (m) | (m) | $1.11M | $1.03B | (m) | (m) | $4.03B | (m) |
| 2015-06-28 | (m) | (m) | $1.97M | $986.45M | (m) | (m) | $4.08B | (m) |
| 2015-03-29 | (m) | (m) | $1.08M | $1.01B | (m) | (m) | $4.03B | (m) |
| 2014-12-28 | (m) | (m) | (m) | $1.05B | (m) | (m) | $4.13B | (m) |
| 2014-09-28 | (m) | (m) | $1.16M | $858.58M | (m) | (m) | $3.89B | (m) |
| 2014-06-29 | (m) | (m) | $1.05M | $894.28M | (m) | (m) | $3.94B | (m) |
| 2014-03-30 | (m) | (m) | $2.63M | $926.90M | (m) | (m) | $3.97B | (m) |
| 2013-12-29 | (m) | (m) | (m) | $932.10M | (m) | (m) | $3.95B | (m) |
| 2013-09-29 | (m) | (m) | $2.62M | $933.29M | (m) | (m) | $3.85B | (m) |
| 2013-06-30 | (m) | (m) | $2.21M | $1.00B | (m) | (m) | $3.81B | (m) |
| 2013-03-31 | (m) | (m) | $7.30M | $1.02B | (m) | (m) | $3.81B | (m) |
| 2012-12-30 | (m) | (m) | (m) | $938.82M | (m) | (m) | $3.90B | (m) |
| 2012-09-30 | (m) | (m) | $1.47M | $930.86M | (m) | (m) | $3.89B | (m) |
| 2012-07-01 | (m) | (m) | (m) | $911.04M | (m) | (m) | $3.80B | (m) |
| 2012-04-01 | (m) | (m) | (m) | $933.97M | (m) | (m) | $3.86B | (m) |
| 2012-01-01 | (m) | (m) | (m) | $944.91M | (m) | (m) | $3.83B | (m) |
| 2011-10-02 | (m) | (m) | $358.00M | $150.00M | (m) | (m) | $3.40B | (m) |
| 2011-07-03 | (m) | (m) | (m) | $671.00M | (m) | (m) | $3.60B | (m) |
| 2011-04-03 | (m) | (m) | (m) | $514.00M | (m) | (m) | $3.31B | (m) |
| 2011-01-02 | (m) | (m) | (m) | $424.00M | (m) | (m) | $3.21B | (m) |
| 2010-10-03 | (m) | (m) | (m) | $670.13M | (m) | (m) | $3.25B | (m) |
| 2010-07-04 | (m) | (m) | (m) | $620.14M | (m) | (m) | $3.15B | (m) |
| 2010-01-03 | (m) | (m) | (m) | $558.20M | (m) | (m) | $3.06B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |